Literature DB >> 22524816

p53 exon 4 (codon 72) polymorphism and exon 7 (codon 249) mutation in breast cancer patients in southern region (Madurai) of Tamil Nadu.

Kiruthiga Perumal Vijayaraman1, Mohanasundari Veluchamy, Pravina Murugesan, Karutha Pandian Shanmugiah, Pandima Devi Kasi.   

Abstract

BACKGROUND: We investigated the association between polymorphisms in the p53 tumor suppressor gene and breast cancer risk in women especially in the Southern part of India.
METHODS: Genotyping was performed for 50 breast cancer women and 50 controls to determine the status of p53 exon 4 codon 72 polymorphism and exon 7 codon 249 mutation and their possible role in breast cancer risk.
RESULTS: Frequency of Arg/Arg at codon 72 was 18% in controls and 28% in patients, Arg/Pro frequency was 56% and 66%, Pro/Pro genotype was 8% in controls and 8% in patients. No significance was observed for breast cancer risk with either Arg/Arg or Pro/Pro genotype in codon 72 polymorphism. Similarly, mutation analysis of exon 7 codon 249 revealed that 72% of breast cancer patients have mutation, which is not statistically significant. However, there is a strong association between increase in exon 7 codon 249 mutation and exposure to pollution.
CONCLUSION: The results suggested that there is no risk for exon 4 with Arg/Arg or Pro/Pro polymorphisms in the p53 gene and there is no strong correlation between breast cancer patients and mutation in exon 7 codon 249 in South Indian women.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22524816     DOI: 10.7314/apjcp.2012.13.2.511

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  9 in total

1.  Association of p53 codon 72 polymorphism and survival of North Indian lung cancer patients treated with platinum-based chemotherapy.

Authors:  Ankita Kumari; Charu Bahl; Navneet Singh; Digambar Behera; Siddharth Sharma
Journal:  Mol Biol Rep       Date:  2016-09-10       Impact factor: 2.316

2.  Breast cancer risk in relation to TP53 codon 72 and CDH1 gene polymorphisms in the Bangladeshi women.

Authors:  Samia Shabnaz; Maizbha Uddin Ahmed; Md Siddiqul Islam; Md Reazul Islam; Mir Md Abdullah Al-Mamun; Mohammad Safiqul Islam; Abul Hasnat
Journal:  Tumour Biol       Date:  2015-12-14

3.  Clinical significance of TP53 (R72P) and MDM2 (T309G) polymorphisms in breast cancer patients.

Authors:  P Yadav; M Masroor; K Tanwer; R Mir; J Javid; I Ahmad; M Zuberi; R C M Kaza; S K Jain; N Khurana; P C Ray; A Saxena
Journal:  Clin Transl Oncol       Date:  2015-11-09       Impact factor: 3.405

4.  Detection of TP53 R249 Mutation in Iranian Patients with Pancreatic Cancer.

Authors:  Ashraf Mohamadkhani; Elnaz Naderi; Maryam Sharafkhah; Hamid Reza Fazli; Malihe Moradzadeh; Akram Pourshams
Journal:  J Oncol       Date:  2013-12-30       Impact factor: 4.375

5.  Assessment of changes in the BRCA2 and P53 genes in breast invasive ductal carcinoma in northeast Brazil.

Authors:  Eduardo Avf Ramalho; João Lq Silva-Filho; Marina Fs Cartaxo; Carmelita Bl Cavalcanti; Moacyr Jbm Rêgo; Maria Bm Oliveira; Eduardo Ic Beltrão
Journal:  Biol Res       Date:  2014-03-26       Impact factor: 5.612

6.  Co-expression of ING4 and P53 enhances hypopharyngeal cancer chemosensitivity to cisplatin in vivo.

Authors:  Xin Ren; Hao Liu; Mingjie Zhang; Mengjun Wang; Shiyin Ma
Journal:  Mol Med Rep       Date:  2016-07-27       Impact factor: 2.952

7.  The Evaluation of p53 Polymorphism at Codon 72 and Association With Breast Cancer in Iran: A Systematic Review and Meta-analysis.

Authors:  Abozar Soleimani; Yousef Rahmani; Negin Farshchian; Ali Delpisheh; Kivan Khassi; Afshar Shahmohammadi; Nasrin Amirifard
Journal:  J Cancer Prev       Date:  2016-12-30

8.  Impact of p53 arg72pro SNP on Breast Cancer Risk in North Indian Population.

Authors:  Naseem Akhter; Sajad A Dar; Shilpi Chattopadhyay; Shafiul Haque; Razique Anwer; Mohd Wahid; Arshad Jawed; Mohtashim Lohani; Raju K Mandal; N K Shukla; Yasir Abdul; Syed Akhtar Husain
Journal:  Curr Genomics       Date:  2018-08       Impact factor: 2.236

9.  Association of TP53 PIN3 polymorphism with breast cancer in Moroccan population.

Authors:  Chaymaa Marouf; Amal Tazzite; Brehima Diakité; Hassan Jouhadi; Abdellatif Benider; Sellama Nadifi
Journal:  Tumour Biol       Date:  2014-09-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.